Literature DB >> 26994682

Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.

Bethany T Samuelson1, Terry Gernsheimer2, Elihu Estey2, David A Garcia2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26994682      PMCID： PMC5308208          DOI： 10.1016/j.thromres.2016.03.011

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  2 in total

1.  Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH.

Authors:  M Carrier; A A Khorana; J I Zwicker; S Noble; A Y Y Lee
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

2.  The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.

Authors:  David E Gerber; Jodi B Segal; M Yair Levy; Joyce Kane; Richard J Jones; Michael B Streiff
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113
  2 in total
  9 in total

1.  Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation.

Authors:  Ang Li; Chris Davis; Qian Wu; Shan Li; Madeline F Kesten; Leona A Holmberg; Ajay K Gopal; David A Garcia
Journal:  Blood Adv       Date:  2017-04-27

Review 2.  Challenging clinical scenarios for therapeutic anticoagulation: A practical approach.

Authors:  Kylee L Martens; Simone E Dekker; Megan Crowe; Thomas G DeLoughery; Joseph J Shatzel
Journal:  Thromb Res       Date:  2022-08-19       Impact factor: 10.407

3.  Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists.

Authors:  Allyson M Pishko; Mudi Misgav; Adam Cuker; Douglas B Cines; James N George; Sara K Vesely; Deirdra R Terrell
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

4.  Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.

Authors:  B T Samuelson Bannow; R B Walter; T B Gernsheimer; D A Garcia
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

5.  Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.

Authors:  Damon E Houghton; Nigel S Key; Neil A Zakai; Jeffrey P Laux; Thomas C Shea; Stephan Moll
Journal:  Leuk Lymphoma       Date:  2017-04-09

6.  Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review.

Authors:  Bethany R Samuelson Bannow; Agnes Y Y Lee; Alok A Khorana; Jeffrey I Zwicker; Simon Noble; Cihan Ay; Marc Carrier
Journal:  Res Pract Thromb Haemost       Date:  2018-06-19

Review 7.  Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.

Authors:  Claudia Cristina Tărniceriu; Loredana Liliana Hurjui; Irina Daniela Florea; Ion Hurjui; Irina Gradinaru; Daniela Maria Tanase; Carmen Delianu; Anca Haisan; Ludmila Lozneanu
Journal:  Medicina (Kaunas)       Date:  2022-02-01       Impact factor: 2.430

8.  Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.

Authors:  Damon E Houghton; Henny Heisler Billett; Manila Gaddh; Oluwatomiloba Onadeko; Gemlyn George; Tzu-Fei Wang; Thein H Oo; Mingen Feng; Mahua Dasgupta; Michael Jaglal; Michael B Streiff; Pippa Simpson; Radhika Gali; Lisa Baumann Kreuziger
Journal:  Blood Adv       Date:  2021-07-27

9.  Splenectomy for benign and malignant hematologic pathology: Modern morbidity, mortality, and long-term outcomes.

Authors:  Wilson M Alobuia; Kenneth Perrone; David J Iberri; Rondeep S Brar; David A Spain; Joseph D Forrester
Journal:  Surg Open Sci       Date:  2020-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.